GH logo

Guardant Health Inc (GH)

Guardant Health, Inc., a precision oncology company, provides blood and tissue tests, and data sets in the United States and internationally. The company offers Guardant360 CDx test, a liquid biopsy test for tumor mutation profiling; Guardant360 Liquid test, which measures 740+ genes and supports all guideline-recommended biomarkers; Guardant Reveal test, a...

NASDAQHealthcareDiagnostics & ResearchUSA

公司簡介

股票程式碼
GH
ISIN程式碼
US40131M1099
貨幣
US Dollar (USD)
IPO日期
2018-10-04

聯絡資訊

公司地址
3100 Hanover Street, Palo Alto, CA, United States, 94304
聯絡電話
855 698 8887
公司網站
https://guardanthealth.com
財年結束
December

財務亮點

市值
$999,999.99
毛利潤(TTM)
$999,999.99
資產回報率(TTM)
-18.07%
EBITDA
$-999,999.99
收入(TTM)
$999,999.99